US experts call for novel approaches to monitoring clinical trials
This article was originally published in RAJ Devices
The Clinical Trials Transformation Initiative (CTTI), a major US venture to modernise the way that clinical trials are conducted, has published a summary of its deliberations on how sponsors can best monitor the conduct of clinical trials1,2. The discussions on how to monitor the conduct of clinical trials effectively and efficiently as a component of quality were published in May by the CTTI, which comprises experts from the Food and Drug Administration and Duke University.
You may also be interested in...
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
In the second segment of a two-part article on transparency provisions for the new EU clinical trial portal, a senior Merck executive explains how the company will ensure that commercially sensitive information and personal data in its clinical trial applications are not made public.